Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +12.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (494)

clinicaltrialsPublishedShowing 251–300 of 427 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04559230	Sacituzumab Govitecan in Recurrent Glioblastoma	recruiting	Phase 2	32	The University of Texas Health Science Center at San AntonioOTHER	1	Mar 30, 2026	clinicaltrials
NCT04947319	Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)	active not recruiting	Phase 2	119	Ono Pharmaceutical Co., Ltd.INDUSTRY	1	Mar 30, 2026	clinicaltrials